Major Cancer Research Center Signs New $3.5 Million, Multiyear Commitment to OmniComm's TrialMaster® EDC

Stock Information for OmniComm Systems Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About OmniComm Systems Inc

Top 5 Global CRO Places Contract for OmniComm's Newly Released Leading-Edge AutoEncoder
Hitachi Inspharma Partners With OmniComm to Offer eClinical Solutions in Japan
Surrey Clinical Research Centre Signs Five-Year Contract Renewal With OmniComm Systems
International Biopharmaceutical Company Selects OmniComm's TrialMaster® EDC for Multi-Study Cancer Research
OmniComm Systems, Inc. Reports Financial Results for the Year-to-Date and Quarter Ending September 30, 2018
OmniComm Attracts Industry Leaders for the 8th Annual Innovation Forum
Global CRO Signs Seven-Year TrialOne® Agreement With OmniComm Systems
Sorrento Therapeutics Selects OmniComm's TrialMaster® EDC for Cancer Research

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.